Wockhardt Limited (NSE:WOCKPHARMA)
India flag India · Delayed Price · Currency is INR
1,819.00
-2.00 (-0.11%)
Jul 17, 2025, 3:30 PM IST

Wockhardt Company Description

Wockhardt Limited, a pharmaceutical and biotech company, manufactures and trades pharmaceuticals, medicinal, botanical, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally.

The company develops qualified infectious diseases products comprising WCK5222, which is in phase 3 clinical trial for the treatment of sepsis and hospital/ventilator associated pneumonia; WCK 4282, which is in phase 3 clinical trial for ESBL infections; WCK 6777, which is phase 1 to treat gram negative infections; and WCK 4873, which is phase 3 clinical trial for community-acquired bacterial pneumonia.

It also offers rapid and long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices.

In addition, the company develops and commercializes Biovac-B, a hepatitis B vaccine; WEPOX, a recombinant human erythropoietin; WOSULIN, a recombinant human insulin; and GLARITUS, a recombinant insulin glargine.

Further, it provides contract manufacturing services; offers and active pharmaceutical ingredients. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.

Wockhardt Limited
Wockhardt logo
CountryIndia
Founded1967
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees2,386
CEOMurtaza Khorakiwala

Contact Details

Address:
Wockhardt Towers
Mumbai, Maharashtra 400051
India
Phone91 24 0669 4444
Websitewockhardt.com

Stock Details

Ticker SymbolWOCKPHARMA
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE049B01025
SIC Code2834

Key Executives

NamePosition
Dr. Habil Fakhruddin KhorakiwalaFounder and Executive Chairman
Dr. Murtaza Habil KhorakiwalaMD and Executive Director
Dr. Huzaifa Habil KhorakiwalaExecutive Director
Deepak R. MadnaniChief Financial Officer
Dr. Mahesh Vithalbhai PatelChief Scientific Officer of New Drug Discovery
Debolina PartapSenior Vice President of Legal
Neeraj AgarwalChief Human Resource Officer
Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMASenior Vice President of Business Development
Zoher T. SihorwalaHead of Global Regulatory Affairs
Prakash GuptaPresident of Supply Chain